Chandigarh

HE-ROSE: FROM THE BHAGAVAD GITA TO THE ILIAD, THE EMBRACE OF ARJUNA AND ACHILLES.

April 16, 2024 03:43 PM

A COLLABORATION BETWEEN THE FRENCH SCHOOL ENSATT AND THE INDIAN THEATRE TROUPE ADISHAKTI LABORATORY, HE-ROSE WILL BE STAGED AT THE TAGORE THEATRE ON WEDNESDAY 

  Face2News/Chandigarh 

HE-ROSE - a powerful theatrical performance which connects the Bhagavad Gita to the Iliad, the embrace of Arjuna and Achilles, will be staged at Tagore Theatre in Sector 18 Chandigarh at 7:30 pm on Wednesday. 

The Cultural French network in India and the National School of Drama are presenting the He-ROSE show, the Adishakti-Ensatt play, which premiered in Lyon, France a few months ago.

Written by Nimmy Raphel and directed by Vinay Kumar of Adishakti and assisted by Amaud Guennad of ENSATT, HE-ROSE depicts the tragic saga of two mythological heroes, Arjuna from Veda Vyasa’s Bhagavad Gita and Achilles from Homer’s Iliad. The play HE-ROSE is about two personalities from two different cultures and in a liminal realm between glory and tragedy.

He-ROSE exemplifies the power of the Indo-French cultural collaboration, with artists from diverse backgrounds coming together to set yet another example of creativity. After a 3- week residency that took place last August at Auroville in Pondicherry, eight students from French school ENSATT were invited to train and work on the staging of the play with Adishakti professionals, under the mentorship of Director Nimmy Raphel. 

At the heart of He-Rose lies a profound inquiry into the nature of heroism. Drawing parallels between iconic figures such as Arjuna from the Mahabharata and Achilles from the Iliad, the production challenges conventional notions of heroism, inviting audiences to contemplate the interplay between vulnerability and courage. 

Key Details:

Date: April 17, 2024 Time: 7:30 pm

Location: Tagore Theatre, Sector - 18, Chandigarh

Performance: Theatre and Dance Play (1 hour)

Language: English

Entry: Free

 
Have something to say? Post your comment
Copyright © , Face 2 News, All rights reserved. Terms & Conditions Privacy Policy Disclaimers